Glucose sensitivity and metabolism-secretion coupling studied during two-year continuous culture in INS-1E insulinoma cells
- PMID: 14592952
- DOI: 10.1210/en.2003-1099
Glucose sensitivity and metabolism-secretion coupling studied during two-year continuous culture in INS-1E insulinoma cells
Abstract
Rat insulinoma-derived INS-1 cells constitute a widely used beta-cell surrogate. However, due to their nonclonal nature, INS-1 cells are heterogeneous and are not stable over extended culture periods. We have isolated clonal INS-1E cells from parental INS-1 based on both their insulin content and their secretory responses to glucose. Here we describe the stable differentiated INS-1E beta-cell phenotype over 116 passages (no. 27-142) representing a 2.2-yr continuous follow-up. INS-1E cells can be safely cultured and used within passages 40-100 with average insulin contents of 2.30 +/- 0.11 microg/million cells. Glucose-induced insulin secretion was dose-related and similar to rat islet responses. Secretion saturated with a 6.2-fold increase at 15 mm glucose, showing a 50% effective concentration of 10.4 mm. Secretory responses to amino acids and sulfonylurea were similar to those of islets. Moreover, INS-1E cells retained the amplifying pathway, as judged by glucose-evoked augmentation of insulin release in a depolarized state. Regarding metabolic parameters, INS-1E cells exhibited glucose dose-dependent elevations of NAD(P)H, cytosolic Ca(2+), and mitochondrial Ca(2+) levels. In contrast, mitochondrial membrane potential, ATP levels, and cell membrane potential were all fully activated by 7.5 mm glucose. Using the perforated patch clamp technique, 7.5 and 15 mm glucose elicited electrical activity to a similar degree. A K(ATP) current was identified in whole cell voltage clamp using diazoxide and tolbutamide. As in native beta-cells, tolbutamide induced electrical activity, indicating that the K(ATP)conductance is important in setting the resting potential. Therefore, INS-1E cells represent a stable and valuable beta-cell model.
Similar articles
-
Activation of KATP channels by H2S in rat insulin-secreting cells and the underlying mechanisms.J Physiol. 2005 Dec 1;569(Pt 2):519-31. doi: 10.1113/jphysiol.2005.097642. Epub 2005 Sep 22. J Physiol. 2005. PMID: 16179362 Free PMC article.
-
Enhanced stimulus-secretion coupling in polyamine-depleted rat insulinoma cells. An effect involving increased cytoplasmic Ca2+, inositol phosphate generation, and phorbol ester sensitivity.J Clin Invest. 1993 Oct;92(4):1910-7. doi: 10.1172/JCI116784. J Clin Invest. 1993. PMID: 8408643 Free PMC article.
-
Association of upregulated activity of K(ATP) channels with impaired insulin secretion in UCP1-expressing insulinoma cells.J Physiol. 2002 May 1;540(Pt 3):781-9. doi: 10.1113/jphysiol.2001.013048. J Physiol. 2002. PMID: 11986368 Free PMC article.
-
Ion channels, electrical activity and insulin secretion.Diabete Metab. 1994 Mar-Apr;20(2):138-45. Diabete Metab. 1994. PMID: 7528694 Review.
-
Physiological and pharmacological regulation of insulin release: insights offered through exploitation of insulin-secreting cell lines.Diabetes Obes Metab. 1999 May;1(3):137-50. doi: 10.1046/j.1463-1326.1999.00017.x. Diabetes Obes Metab. 1999. PMID: 11220292 Review. No abstract available.
Cited by
-
Pioglitazone Phases and Metabolic Effects in Nanoparticle-Treated Cells Analyzed via Rapid Visualization of FLIM Images.Molecules. 2024 May 4;29(9):2137. doi: 10.3390/molecules29092137. Molecules. 2024. PMID: 38731628 Free PMC article.
-
(Re-)Viewing Role of Intracellular Glucose Beyond Extracellular Regulation of Glucose-Stimulated Insulin Secretion by Pancreatic Cells.ACS Omega. 2024 Feb 29;9(10):11755-11768. doi: 10.1021/acsomega.3c09171. eCollection 2024 Mar 12. ACS Omega. 2024. PMID: 38496986 Free PMC article.
-
In situ structure of actin remodeling during glucose-stimulated insulin secretion using cryo-electron tomography.Nat Commun. 2024 Feb 12;15(1):1311. doi: 10.1038/s41467-024-45648-7. Nat Commun. 2024. PMID: 38346988 Free PMC article.
-
Binding mechanism and biological effects of flavone DYRK1A inhibitors for the design of new antidiabetics.Sci Rep. 2023 Oct 23;13(1):18114. doi: 10.1038/s41598-023-44810-3. Sci Rep. 2023. PMID: 37872245 Free PMC article.
-
Targeting β Cells with Cathelicidin Nanomedicines Improves Insulin Function and Pancreas Regeneration in Type 1 Diabetic Rats.ACS Pharmacol Transl Sci. 2023 Oct 3;6(10):1544-1560. doi: 10.1021/acsptsci.3c00218. eCollection 2023 Oct 13. ACS Pharmacol Transl Sci. 2023. PMID: 37854630
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous